BioNTech SE (BNTX) Receivables Refunds (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Receivables Refunds data on file, last reported at $61.2 million in Q4 2025.

• In Q4 2025, Receivables Refunds rose 14.6% year-over-year to $61.2 million; the TTM figure through Dec 2025 stood at $61.2 million (up 14.6% YoY), while the FY2025 annual figure was $59.4 million, up 11.23% from the prior year.
• Receivables Refunds slipped to $61.2 million in Q4 2025, from $99.1 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $571.7 million in Q1 2023 and bottomed at $403309.7 in Q3 2022.
• A 5-year average of $141.7 million and a median of $71.3 million in 2025 frame the typical range for Receivables Refunds.
• Annual changes were most pronounced in 2023 — Receivables Refunds soared 127237.31% — and 2025, when it plunged 78.57%.
• Year by year, Receivables Refunds stood at $457588.4 in 2021, then retreated by 10.82% to $408098.9 in 2022, then surged by 47119.15% to $192.7 million in 2023, then tumbled by 72.27% to $53.4 million in 2024, then rose by 14.6% to $61.2 million in 2025.
• The last three Receivables Refunds figures came in at $61.2 million (Q4 2025), $99.1 million (Q3 2025), and $78.9 million (Q2 2025), per Business Quant data.

Peer Comparison